Life science reagents, assays, and instrumentation for research and diagnostics
Promega manufactures bioluminescent assays, nucleic acid reagents, and protein analysis tools for academic, pharmaceutical, and diagnostic labs worldwide. The tech stack reflects a traditional manufacturing-operations footprint (SAP, VMware, Hyper-V) with recent GPT and ChatGPT adoption, while active projects center on cell health assay development, AI integration into operations, and cost-reduction initiatives—suggesting a company modernizing workflows while maintaining core lab-chemistry IP.
Promega develops and manufactures reagents, assays, and instrumentation used by life scientists across academic, pharmaceutical, diagnostic, and government sectors. The company operates 16 global branches and serves customers pursuing basic biological research, disease diagnosis and treatment development, and genetic testing applications. Core specialties include nucleic acid isolation and amplification, protein expression and analysis, cell-based assays, luminescent chemistries, and custom manufacturing and assay services. Founded in 1978, Promega operates with 1,001–5,000 employees and maintains headquarters in Madison, Wisconsin.
Promega manufactures life science reagents and assays—nucleic acid isolation kits, bioluminescent assays for food safety and water quality monitoring, protein expression systems, and cell-based biochemical assays used by research and diagnostic labs globally.
Promega is headquartered in Madison, Wisconsin. The company operates 16 branches worldwide and actively hires in the United States, South Korea, Singapore, and Germany.
Promega is integrating AI into operations and upgrading network technology infrastructure. Active projects also include cell health assay development, cost-reduction initiatives, prototype production, and hybrid environment integration using existing infrastructure (SAP, Azure Stack, VMware).
Other companies in the same industry, closest in size